G. W. Kuron
Impact in
- Biotechnology top 0.5%
- Microbial Metabolism and Applications
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
- Pharmacological Effects of Natural Compounds
Papers in
-
- Plant biochemistry and biosynthesis 3
- Peroxisome Proliferator-Activated Receptors 2
- Oncology 3
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- V. M. Hunt (3 shared papers)Alfred W. Alberts (3 shared papers)Jesse W. Huff (2 shared papers)Richard L. Monaghan (1 shared paper)G. Albers‐Schönberg (1 shared paper)Arthur A. Patchett (1 shared paper)Susan Currie (1 shared paper)Cecilia Hoffman (1 shared paper)
- Journals
- Experimental Biology and Medicine (5 papers)European Journal of Clinical Pharmacology (2 papers)Journal of Lipid Research (1 paper)Journal of Chromatography A (1 paper)Journal of Chromatographic Science (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
G. W. Kuron
12 papers receiving 1.4k citations
G. W. Kuron's Hit Papers
Peers
Comparison fields: 5 of 91
- Biotechnology 720
- Pharmacology 553
- Pharmacology 134
- Biochemistry 78
- Molecular Biology 859
Countries citing papers authored by G. W. Kuron
This map shows the geographic impact of G. W. Kuron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. W. Kuron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. W. Kuron more than expected).
Fields of papers citing papers by G. W. Kuron
This network shows the impact of papers produced by G. W. Kuron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. W. Kuron. The network helps show where G. W. Kuron may publish in the future.
Co-authors
The 25 scholars most cited alongside G. W. Kuron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Hit paper breakdown → | 1980 | 1298 |
| 2 | 1960 | 115 | |
| 3 | 1991 | 23 | |
| 4 | 1991 | 15 | |
| 5 | 1957 | 11 | |
| 6 | 1964 | 11 | |
| 7 | 1958 | 8 | |
| 8 | 1961 | 7 | |
| 9 | 1980 | 7 | |
| 10 | 1957 | 3 | |
| 11 | 1969 | 2 | |
| 12 | 1968 | 2 |
About G. W. Kuron
G. W. Kuron is a scholar working on Molecular Biology, Oncology, Physiology, Biotechnology and Surgery, having authored 12 papers that have together received 1.5k indexed citations. Recurring topics across this work include Plant biochemistry and biosynthesis (3 papers), Microbial Metabolism and Applications (3 papers), Diet and metabolism studies (3 papers), Computational Drug Discovery Methods (2 papers), Cholesterol and Lipid Metabolism (2 papers), Analytical Chemistry and Chromatography (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Biotechnology (720 citations), Pharmacology (553 citations), Pharmacology (134 citations), Biochemistry (78 citations) and Molecular Biology (859 citations). G. W. Kuron has collaborated with scholars based in United States and Germany. Frequent co-authors include V. M. Hunt, Alfred W. Alberts, Jesse W. Huff, Richard L. Monaghan, G. Albers‐Schönberg, Arthur A. Patchett, Susan Currie, Cecilia Hoffman, J. HIRSHFIELD and M López. Their work appears in journals such as Experimental Biology and Medicine, European Journal of Clinical Pharmacology, Journal of Lipid Research, Journal of Chromatography A and Journal of Chromatographic Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.